open access

Vol 1, No 3 (2016)
ORIGINAL PAPERS
Published online: 2016-11-04
Get Citation

Evaluating the safety and efficacy of photorefractive keratectomy combined with corneal collagen crosslinking for the treatment of myopia and myopic astigmatism

Ioannis A. Mallias, Panagiota Mylova, Aikaterini Mouzaka, Ronis Christidis, Anastasia Tasiopoulou
DOI: 10.5603/OJ.2016.0015
·
Ophthalmol J 2016;1(3):79-82.

open access

Vol 1, No 3 (2016)
ORIGINAL PAPERS
Published online: 2016-11-04

Abstract

INTRODUCTION. The purpose of the study was to evaluate the safety and efficacy of photorefractive keratectomy (PRK) combined with corneal collagen crosslinking (CXL) in patients with potential risk of developing postoperative ectasia, who were not good candidates for LASIK.

MATERIALS AND METHODS. Twenty eyes were treated with transepithelial PRK combined with CXL. Patients were evaluated preoperatively for best corrected visual acuity (BCVA), refraction, keratometry, topography, and endothelial cell count. All eyes were treated with Amaris 750s Excimer Laser and KXL system for 90 seconds at 30 mW/cm2.

RESULTS. Mean BCVA was improved from 0.0075 ± 0.08 logMAR to 0.025 ± 0.05 logMAR postoperatively. Average keratometry reduced from 44.9 ± 1.9 D to 39.8 ± 3.9 D. Mean minimal corneal thickness reduced from 504 ± 16.7 μm to 405 ± 41 μm. None of the cases developed regression, corneal ectasia, or corneal haze.

CONCLUSIONS. Photorefractive keratectomy combined with high-fluence corneal collagen crosslinking (PRK XTRA) appears to be a safe and effective treatment for patients who are not good candidates for LASIK.

Abstract

INTRODUCTION. The purpose of the study was to evaluate the safety and efficacy of photorefractive keratectomy (PRK) combined with corneal collagen crosslinking (CXL) in patients with potential risk of developing postoperative ectasia, who were not good candidates for LASIK.

MATERIALS AND METHODS. Twenty eyes were treated with transepithelial PRK combined with CXL. Patients were evaluated preoperatively for best corrected visual acuity (BCVA), refraction, keratometry, topography, and endothelial cell count. All eyes were treated with Amaris 750s Excimer Laser and KXL system for 90 seconds at 30 mW/cm2.

RESULTS. Mean BCVA was improved from 0.0075 ± 0.08 logMAR to 0.025 ± 0.05 logMAR postoperatively. Average keratometry reduced from 44.9 ± 1.9 D to 39.8 ± 3.9 D. Mean minimal corneal thickness reduced from 504 ± 16.7 μm to 405 ± 41 μm. None of the cases developed regression, corneal ectasia, or corneal haze.

CONCLUSIONS. Photorefractive keratectomy combined with high-fluence corneal collagen crosslinking (PRK XTRA) appears to be a safe and effective treatment for patients who are not good candidates for LASIK.

Get Citation

Keywords

PRK, PRK-XTRA, PRK+CXL, crosslinking, high-risk patients, ectasia

About this article
Title

Evaluating the safety and efficacy of photorefractive keratectomy combined with corneal collagen crosslinking for the treatment of myopia and myopic astigmatism

Journal

Ophthalmology Journal

Issue

Vol 1, No 3 (2016)

Pages

79-82

Published online

2016-11-04

DOI

10.5603/OJ.2016.0015

Bibliographic record

Ophthalmol J 2016;1(3):79-82.

Keywords

PRK
PRK-XTRA
PRK+CXL
crosslinking
high-risk patients
ectasia

Authors

Ioannis A. Mallias
Panagiota Mylova
Aikaterini Mouzaka
Ronis Christidis
Anastasia Tasiopoulou

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl